Health Condition 1: N920- Excessive and frequent menstruation with regular cycle Health Condition 2: null- Kasrat e tams (Heavy Menstrual Bleding)
Conditions
Interventions
Intervention1: Qurs-e-Habis: Qurs-e-Habis solid oral 1 tab (250mg) two time to be taken with water 12 hourly after meal 12 weeks
Control Intervention1: Nil: Nil
Sponsors
Central Council For Research In Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non- gravid - non menopausal females with age 19-45years 2. Patients with menorrhagia as indicated by : (i) Excessive Menstrual loss > 80ml/cycle as calculated by menstrual pictogram (attached as annexure) (ii) Menstrual cycle greater than 6 days
Exclusion criteria
Exclusion criteria: 1. Heavy Menstrual Bleeding with structural or histological abnormality, with symptoms such as intermenstrual or post-coital bleeding, pelvic pain and/or pressure symptoms 2. Patients presenting with Heavy Menstrual Bleeding since menarche 3. Patients with a personal or family history suggesting acoagulation disorder 4. Patients using Intrauterine Contraceptive Devices 5. Patients with illness requiring long term treatment e.g. Hypertension, TB etc 6. Patients with Post-menopausal bleeding, 7. Patients with Heavy Menstrual Bleeding taking Hormone Replacement Therapy 8. Conditions where Heavy Menstrual Bleeding is not the main presenting menstrual symptom eg endometriosis 9. Pregnant and lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement in the sign and symptoms of Kasrat e tams (Heavy Menstrual Bleeding)Timepoint: Twelve Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Hematological and biochemical assessments for safetyTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed